CRO partners to crack South America

By Nick Taylor

- Last updated on GMT

Related tags: South america, Clinical trial

Switzerland-based CRO PFC Pharma Focus is entering the South American market through a partnership with Argentinean company Blanchard y Asociados.

The Swiss contract research organisation (CRO) is hoping Blanchard y Asociados will facilitate its entry into the South American market by offering assistance with training and sharing its contacts with experts based in the region.

Entry into South America is the latest of PFC’s attempts to establish itself as a global presence, having previously opened offices or formed partnerships in Europe, the US and Asia.

Ran Frenkel, vice president of business development at PFC said: “PFC is very pleased with partnering with Blanchard & Asociados and with expanding our global presence. We believe that the South American market is an attractive region for our company. With our modular project management we can give our clients quick and cost-effective answers from crafting an effective proposal to successful study completion​.

Entering South America will enhance our abilities to give direct answers to the growing demands of our clients. It is important for us to maintain our high standards and core values and we believe we find an appropriate partner in Blanchard & Asociados​.”

PFC will offer its clients in South America the same services that it provides to customers in other regions. These include clinical trial management and services such as monitoring, patient recruitment and regulatory affairs.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more